HIGHLIGHTS
SUMMARY
Alzheimer`s disease is often described as a disease of brain and/or peripheral inflammation, involving an "over-activation" of the immune system and ensuing elevated cytokine levels in brain (Hu et_al, 2019) and/or blood (Fila, 2010; RubioPerez and Morillas-Ruiz, 2012; Sopova et_al, 2014; Webers et_al, 2020). In AD patients, low levels of GCSF and IL-15 have been reported (Renzos et_al, 2007; Laske et_al, 2009) and faster disease progression was found in AD patients with low plasma cytokine levels compared to those with high levels (Taipa et_al, 2019). The authors have . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.